专利详细信息
| 专利号 |
 |
| 专利标题 | Pharmaceutical Formulation Comprising Metformin and Repaglinide |
| 专利权人 | NOVO NORDISK AS [DK]; |
| 发明人 | HOEJGAARD BENT [DK]; KNUDSEN BREIAN [DK]; RASMUSSEN STELLA RUDKJAER [DK]; JACOBSEN LENE ORUP [DK]; |
| 申请号 | US201314079127 |
| 申请日 | 2013/11/13 |
| 公开日 | 2014/3/6 |
| 优先权号 |
US201314079127 20131113 EP20060121562 20060929 US201113205678 20110809 US20090442432 20090506 WO2007EP60343 20070928 |
| IPC | A61K0031451; A61K0031155; |
| 专利类型 | |
| 法律状态查询 | 查看法律状态 |
The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof
| 专利号 | 专利名称 | 专利权人 | 优先权号 |
|---|---|---|---|
| US2010029721A1 | Pharmaceutical Formulation Comprising Metformin and Repaglinide | NOVO NORDISK AS [DK]; | EP20060121562 WO2007EP60343 |
| WO2008037807A1 | PHARMACEUTICAL FORMULATION COMPRISING METFORMIN AND REPAGLINIDE | NOVO NORDISK AS [DK];HOEJGAARD BENT [DK];KNUDSEN BREIAN [DK];RASMUSSEN STELLA RUDKJAER [DK];JACOBSEN LENE ORUP [DK]; | EP20060121562 |
| EP2073796A1 | PHARMACEUTICAL FORMULATION COMPRISING METFORMIN AND REPAGLINIDE | NOVO NORDISK AS [DK]; | WO2007EP60343 EP20060121562 EP20070820729 |
| CN101516347A | Pharmaceutical formulation comprising metformin and repaglinide | NOVO NORDISK AS [DK]; | EP20060121562 |
没有相关的数据
暂无附图
注：除CN专利外，本系统默认提供的所有其他中文标题和摘要来自机器翻译。
上传
编辑
标注(0)
下载专利全文
收藏